Department of Nephrology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China; Department of Geriatrics, General Hospital of Central Theater Command, Wuhan, Hubei, 430070, China.
Department of Nephrology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.
Biochem Biophys Res Commun. 2022 May 7;603:21-28. doi: 10.1016/j.bbrc.2022.02.099. Epub 2022 Feb 25.
Chronic kidney disease (CKD) is recognized as a serious global health problem due to its high prevalence and all-cause mortality. The aim of this research was to identify critical biomarkers and construct an integrated model for the early prediction of CKD. By using existing RNA-seq data and clinical information from CKD patients from the Gene Expression Omnibus (GEO) database, we applied a computational technique that combined the random forest (RF) and artificial neural network (ANN) approaches to identify gene biomarkers and construct an early diagnostic model. We generated ROC curves to compare the model with other markers and evaluated the associations of selected genes with various clinical properties of CKD. Moreover, we highlighted two biomarkers involved in energy metabolism pathways: pyruvate dehydrogenase kinase 4 (PDK4) and zinc finger protein 36 (ZFP36). The downregulation of the identified key genes was subsequently confirmed in both unilateral ureteral obstruction (UUO) and ischemia reperfusion injury (IRI) mouse models, accompanied by decreased energy metabolism. In vitro experiments and single-cell sequencing analysis proved that these key genes were related to the energy metabolism of proximal tubule cells and were involved in the development of CKD. Overall, we constructed a composite prediction model and discovered key genes that might be used as biomarkers and therapeutic targets for CKD.
慢性肾脏病(CKD)是一种严重的全球性健康问题,其高患病率和全因死亡率使其备受关注。本研究旨在寻找关键的生物标志物,并构建一个综合模型,以实现 CKD 的早期预测。我们利用来自基因表达综合数据库(GEO)的 CKD 患者的现有 RNA-seq 数据和临床信息,采用了一种结合随机森林(RF)和人工神经网络(ANN)方法的计算技术,以识别基因生物标志物并构建早期诊断模型。我们生成了 ROC 曲线来比较模型与其他标志物,并评估了选定基因与 CKD 各种临床特征的相关性。此外,我们还重点介绍了两个参与能量代谢途径的生物标志物:丙酮酸脱氢酶激酶 4(PDK4)和锌指蛋白 36(ZFP36)。在单侧输尿管梗阻(UUO)和缺血再灌注损伤(IRI)小鼠模型中,我们进一步证实了这些鉴定出的关键基因的下调,同时伴随着能量代谢的降低。体外实验和单细胞测序分析证明,这些关键基因与近端肾小管细胞的能量代谢有关,并参与了 CKD 的发生发展。总的来说,我们构建了一个综合预测模型,并发现了一些可能作为 CKD 生物标志物和治疗靶点的关键基因。